Pharmacolog i Uppsala AB (publ) announces today that the annual report for the financial year 2022 has been published.
The annual report is attached as a PDF and is available on the company's website:
https://pharmacolog.com/investor-relations-2/financial-reports/ (Swedish only, English version will follow).
For more information contact:
Lars Gusch, CEO
Phone: +46 70-223 97 72
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.
Further information regarding the company is available at https://pharmacolog.com/.
The company’s Certified Adviser is Mangold Fondkommission AB.